Every session is graded by clinical readiness, not novelty. You leave knowing which protocols belong in your practice this quarter, which need another trial cycle, and which are not ready for your patients yet.
Because the goal is not to leave with more ideas. The goal is to leave better equipped to practice.
Every session is graded by clinical readiness, not novelty. You leave knowing which protocols belong in your practice this quarter, which need another trial cycle, and which are not ready for your patients yet.
The programming is physician-led and anchored in active clinical practice. MVMNT is built for the clinician who needs to know what the evidence supports right now — with the rigor to act on it responsibly.
Small enough that the question you've been holding back gets answered by the physician who's seen it three hundred times. Not a convention. A cohort.
Not influencer culture. Not trend-chasing wellness. Medicine.

OB/GYN · Menopause · Chief Medical Officer, Hers
CMO of Hers and author of Generation M.

A board-certified OB/GYN in women's health, focused on perimenopause, menopause, and how women's longevity is actually treated.

Yale researcher developing AI-driven biomarkers that quantify biological aging and predict disease risk — published in Nature; Forbes 30 Under 30 in Healthcare, 2025.

Double board-certified anesthesiologist and department chair, Cleveland Clinic–trained, who turned a hospital anesthesia career toward longevity medicine.

A Stanford graduate and former head of product at Pymetrics, now building a precision-medicine company on the vaginal microbiome.

Applies machine learning to the gut microbiome for metabolic longevity. Previously SVP of engineering at HeartFlow, with more than 300 patents to his name.

A board-certified lifestyle medicine physician and NAMS-certified menopause specialist whose telemedicine practice centers on hormone optimization and preventive primary care, and who founded Her Longevity, a women’s longevity conference by physicians, for physicians.

A board-certified physician at the intersection of precision medicine, longevity science, and human performance, with a clinical focus on multi-omic diagnostics — genomics, epigenomics, metabolomics, and microbiomics read together — to extend healthspan, not just lifespan.

A Stanford-trained physician and longevity clinician who matched in hematology-oncology at Columbia before moving to the intersection of medicine and technology, where she now practices preventive and longevity medicine.

A double board-certified reproductive endocrinologist building clinical programs that bring a longevity lens to fertility and reproductive care.

A longevity medicine physician and Harvard Medical School lecturer who advises clinicians and health systems on evidence-based healthspan strategy.

A board-certified physician in aesthetic medicine and co-founder of Alpha Aesthetics Partners.

A preventive cardiologist whose career has centered on a single problem: a cardiovascular risk framework built on male physiology, still applied to women — and the clinical and technological work of closing that gap.

A DMD with nearly two decades in facial aesthetics, focused on regenerative, minimally invasive treatment — PRF, biostimulatory injectables, and facial balancing.

A board-certified anesthesiologist and aesthetic and regenerative medicine physician, Northwestern-trained, with subspecialty fellowships in critical care, pain management, and pharmacology.

Nearly four decades advising physicians and healthcare organizations on regulatory compliance, corporate structure, and transactions. Former in-house counsel to the Florida Medical Association.

Double board-certified in internal medicine and obesity medicine, running a concierge longevity practice focused on metabolic health and body composition — with a clinical emphasis on preventing sarcopenia, including in patients on GLP-1 therapies.

A board-certified emergency medicine physician whose work treats psychedelic and ketamine-assisted care as a discipline of durable behavior change — and links the frameworks behind lasting outcomes to longevity medicine.

A board-certified anesthesiologist whose work treats clinical excellence and a sustainable career as one discipline rather than a trade-off — and who teaches clinicians to build practices that last.

A board-certified gastroenterologist who treats the gut as central to energy and longevity — with a clinical focus on the gut–brain axis, motility, and the hormonal shifts of perimenopause so often missed in midlife women.

A healthcare attorney representing providers before state regulatory boards in licensing and disciplinary matters, and advising on FDA compliance — with a focus on the documentation and consent infrastructure behind emerging therapies. She came to law from inside a Florida health system: strategy, operations, and early telehealth.

A board-certified dermatologist with more than two decades across medical, cosmetic, and surgical dermatology, practiced as a U.S. Navy officer and in private practice.
Every session graded by clinical readiness and anchored in active practice.
The GLP-1 era as the new baseline in metabolic longevity. What the evidence supports today, which signals are real versus marketed, and how to select the right patients without overreaching the data.
Where AI genuinely augments clinical judgment, where it's oversold, and the part of the physician's role it can't replace. A grounded look at what's usable in practice now versus what's still a demo.
Biological age and multi-system aging biomarkers — epigenetic clocks, organ-specific aging — and how to read them without overclaiming. What these measures can and can't tell you in front of a patient.
Turning more data into better healthspan. How to move labs, wearables, and biomarkers from dashboards into actual clinical action within the constraints of a real practice.
What gut data actually changes in practice. A practical look at AI-driven microbiome analysis: what the readouts mean, where the evidence holds, and how to act on it responsibly.
The economics of a longevity practice that lasts. Concierge, cash-pay, and hybrid models compared — what makes each sustainable, and the operational realities behind them.
How longevity-medicine innovation meets regulatory reality — the legal, compliance, and policy terrain clinicians and operators navigate as the field scales.
Why research gaps across women and underrepresented populations persist, and how precision medicine can be the corrective rather than another layer of bias.
Clinical infusion therapy in a longevity practice — the rationale, the safety considerations, and hands-on training. What's evidence-based, what's marketing, and how to run it well.




A private 15-acre peninsula on San Diego Bay. Sessions take place in waterfront rooms with floor-to-ceiling glass. The rest of the time, you're on the water.
The peninsula holds the program. Sessions, labs, and the conversations between them — anchored to a single place, never far from the bay.
The firepit, the bay, and the part of the day that makes the work sustainable.
Longevity medicine is dense work. The setting isn't decoration. It's part of how the work gets done.
A private 15-acre peninsula on San Diego Bay. Sessions take place in waterfront rooms with floor-to-ceiling glass. The rest of the time, you're on the water.


The peninsula holds the program. Sessions, labs, and the conversations between them — anchored to a single place, never far from the bay.

The firepit, the bay, and the part of the day that makes the work sustainable.

Longevity medicine is dense work. The setting isn't decoration. It's part of how the work gets done.
FAQ
Register
MVMNT 2026 is the inaugural gathering. The physicians who register now help define what this becomes.
Founding rate
$500
Through July 31 — $750 after